Biotech · Private company
Allergan
Track this companyFree. Adds Allergan to your Dealase workspace and tells you when its record changes.
Clinical trials252 recruiting or active
Pipeline programs18From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline18
- 011516X (New Artificial Tear Formulation)Phase 3 · Dry Eye Disease (DED)ClinicalTrials.gov · fetched Nov 12, 2026
- Atogepant 60 mgPhase 3 · Episodic MigraineClinicalTrials.gov · fetched Nov 12, 2026
- JUVÉDERM® VOLUMA® XCPhase 3 · Temple HollowingClinicalTrials.gov · fetched Nov 12, 2026
- No-treatment controlPhase 3 · Temple HollowingClinicalTrials.gov · fetched Nov 12, 2026
- REFRESH PLUS®Phase 3 · Dry Eye Disease (DED)ClinicalTrials.gov · fetched Nov 12, 2026
- Systane Ultra MultidosePhase 3 · Dry Eye Disease (DED)ClinicalTrials.gov · fetched Nov 12, 2026
- AGN-151586Phase 2 · Glabellar LinesClinicalTrials.gov · fetched Nov 12, 2026
- Armour® ThyroidPhase 2 · HypothyroidismClinicalTrials.gov · fetched Nov 12, 2026
- Formulation A: OnabotulinumtoxinAPhase 2 · Glabellar LinesClinicalTrials.gov · fetched Nov 12, 2026
- Formulation B: OnabotulinumtoxinAPhase 2 · Glabellar LinesClinicalTrials.gov · fetched Nov 12, 2026
- Formulation C: OnabotulinumtoxinAPhase 2 · Glabellar LinesClinicalTrials.gov · fetched Nov 12, 2026
- LevothyroxinePhase 2 · HypothyroidismClinicalTrials.gov · fetched Nov 12, 2026
- OnabotulinumtoxinA XPhase 2 · Forehead LinesClinicalTrials.gov · fetched Nov 12, 2026
- OnabotulinumtoxinA XPhase 2 · Glabellar LinesClinicalTrials.gov · fetched Nov 12, 2026
- 410 ArmBreast ImplantClinicalTrials.gov · fetched Nov 12, 2026
- BIFs - Breast Implant Follow-Up StudyBreast ImplantClinicalTrials.gov · fetched Nov 12, 2026
- CoolSculpting® Elite System with CoolSculpting® Elite applicatorsNon-invasive Fat ReductionClinicalTrials.gov · fetched Nov 12, 2026
- NBIR - US National Breast Implant RegistryBreast ImplantClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- Feasibility of BOTOX Injection on Improving Female Stress Urinary IncontinenceEARLY_PHASE1 · SUSPENDED · started Feb 14, 2022ClinicalTrials.gov NCT04984317 · fetched Nov 12, 2026
- A Study To Assess the Adverse Effects and Change in Condition of OnabotulinumtoxinA X Injection in Adult Participants With Forehead LinesPHASE2 · COMPLETED · started Nov 29, 2021ClinicalTrials.gov NCT05152576 · fetched Nov 12, 2026
- A Study to the Assess the Change in Condition and Adverse Events of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar LinesPHASE2 · COMPLETED · started Oct 6, 2021ClinicalTrials.gov NCT05100199 · fetched Nov 12, 2026
- A Study of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar LinesPHASE2 · COMPLETED · started Sep 1, 2021ClinicalTrials.gov NCT05013424 · fetched Nov 12, 2026
- Novel Use of Cyclosporine Ophthalmic Emulsion 0.05% in a PROSE DevicePHASE1_PHASE2 · COMPLETED · started Jul 15, 2021ClinicalTrials.gov NCT04918823 · fetched Nov 12, 2026
- CoolSculpting® Elite for Non-Invasive Fat ReductionPHASE4 · COMPLETED · started May 18, 2021ClinicalTrials.gov NCT04897867 · fetched Nov 12, 2026
- Atogepant for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments.PHASE3 · COMPLETED · started Mar 5, 2021ClinicalTrials.gov NCT04740827 · fetched Nov 12, 2026
- 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA)COMPLETED · started Mar 3, 2021ClinicalTrials.gov NCT04647214 · fetched Nov 12, 2026
- Efficacy, Safety, and Tolerability of ATM-AVI in the Treatment of Serious Infection Due to MBL-producing Gram-negative BacteriaPHASE3 · TERMINATED · started Dec 25, 2020ClinicalTrials.gov NCT03580044 · fetched Nov 12, 2026
- Vollure for the Correction of Atrophic Facial ScarringNA · ACTIVE_NOT_RECRUITING · started Nov 11, 2020ClinicalTrials.gov NCT04519515 · fetched Nov 12, 2026
- INflammatory MediatorS in the PathophysIology of Diabetic REtinopathy StudyPHASE1 · COMPLETED · started Nov 9, 2020ClinicalTrials.gov NCT04505566 · fetched Nov 12, 2026
- Jowl Improvement With Injectable FillersNA · COMPLETED · started Sep 25, 2020ClinicalTrials.gov NCT04389866 · fetched Nov 12, 2026
- Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye DiseasePHASE3 · COMPLETED · started Jun 29, 2020ClinicalTrials.gov NCT04393441 · fetched Nov 12, 2026
- A Study Evaluating JUVÉDERM® VOLUMA® XC Injectable Gel for Correction of Temple Hollowing in Adult Participants ≥ 22 Years OldPHASE3 · COMPLETED · started May 28, 2020ClinicalTrials.gov NCT04414397 · fetched Nov 12, 2026
- Comparative Study of Dexamethasone Implant to Intravitreal Aflibercept in Subjects With Diabetic Macular EdemaPHASE4 · COMPLETED · started Apr 10, 2020ClinicalTrials.gov NCT04411693 · fetched Nov 12, 2026
- Evaluation of Pharmacokinetics, Safety, and Tolerability of Ceftazidime-avibactam in Neonates and Infants.PHASE2 · TERMINATED · started Jan 14, 2020ClinicalTrials.gov NCT04126031 · fetched Nov 12, 2026
- A Study of Armour® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid ParticipantsPHASE2 · COMPLETED · started Oct 11, 2019ClinicalTrials.gov NCT04124705 · fetched Nov 12, 2026
- AGN-151586 Dose-Ranging Study for Treatment of Glabellar LinesPHASE2 · COMPLETED · started Sep 26, 2019ClinicalTrials.gov NCT04096326 · fetched Nov 12, 2026
- TrueTear in Sjogren's Disease PatientsNA · COMPLETED · started Dec 1, 2018ClinicalTrials.gov NCT03719885 · fetched Nov 12, 2026
- Steroid vs. Anti-vascular Endothelial Growth Factor for Diabetic Macular Edema Prior to PhacoemulsificationPHASE4 · COMPLETED · started Nov 15, 2018ClinicalTrials.gov NCT03832179 · fetched Nov 12, 2026
- The Effect of a New Emulsion in Dry Eye Patients on Tear Layer Aberrometry, Contrast Sensitivity, and Reading AbilityNA · COMPLETED · started Nov 1, 2009ClinicalTrials.gov NCT01013077 · fetched Nov 12, 2026
- H-22411: BOTOX® for Peyronie's DiseasePHASE2 · COMPLETED · started Aug 7, 2009ClinicalTrials.gov NCT00812838 · fetched Nov 12, 2026
- Study of the Safety and Efficacy of Botox in BruxismPHASE4 · COMPLETED · started Apr 1, 2009ClinicalTrials.gov NCT00908050 · fetched Nov 12, 2026
- Appetite Suppression / Hormone Study Control GroupUNKNOWN · started Sep 1, 2008ClinicalTrials.gov NCT02029677 · fetched Nov 12, 2026
- Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National NormsACTIVE_NOT_RECRUITING · started Nov 1, 2006ClinicalTrials.gov NCT00443274 · fetched Nov 12, 2026